Here come the 2019 uni­corns: Alec­tor, Gos­samer set to launch IPOs don­ning $1B-plus mar­ket caps

Are you ready for swelling biotech IPO val­u­a­tions?

Alec­tor and Gos­samer Bio are set to de­but on Nas­daq lat­er this week at mar­ket caps of $1.4 bil­lion and $1 bil­lion re­spec­tive­ly, mark­ing the first biotech uni­corn list­ings in 2019. The col­lec­tive boun­ty they are shoot­ing for? $406 mil­lion.

Sure, IPO trends can be short lived and the in­dus­try’s crys­tal balls are murky at best, but the duo are emerg­ing from a harsh win­ter last De­cem­ber that rav­aged biotech stocks across the board, with one an­a­lyst de­scrib­ing the mood as sink­ing “be­low dis­in­ter­est to­ward anger.” In par­tic­u­lar, the af­ter­math of Mod­er­na’s record-break­ing $604 mil­lion IPO $MR­NA con­tin­ues to shad­ow the field af­ter watch­ing al­most a third of its mar­ket cap van­ish in­to thin air.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER